Cargando…
Assessing prescribing practices of clozapine before and after the implementation of an updated risk evaluation and mitigation strategy
INTRODUCTION: Clozapine is an atypical antipsychotic medication approved for treatment-resistant schizophrenia and suicidal behavior in schizophrenia or schizoaffective disorders. Despite its therapeutic efficacy, clozapine is associated with several adverse effects, including agranulocytosis. In la...
Autores principales: | Curry, Brent, Palmer, Emma, Mounce, Crystal, Smith, Gilbert, Shah, Vital |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007735/ https://www.ncbi.nlm.nih.gov/pubmed/29955547 http://dx.doi.org/10.9740/mhc.2018.03.063 |
Ejemplares similares
-
Prescribing practices of clozapine in India: Results of a opinion survey of psychiatrists
por: Shrivastava, Amresh, et al.
Publicado: (2009) -
Mandatory certification for clozapine prescribing
por: Cohen, Dan, et al.
Publicado: (2020) -
Antipsychotic polypharmacy and clozapine prescribing patterns: evolution and correlates before and after a psychiatric hospitalisation
por: Lagreula, Juliette, et al.
Publicado: (2022) -
Clozapine & constipation: an audit of bowel habit monitoring and laxative prescribing in inpatients on clozapine
por: Boyd, Holly, et al.
Publicado: (2021) -
Clozapin-Update 2022
por: Qubad, Mishal, et al.
Publicado: (2022)